Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 P900

ECE2006 Poster Presentations Thyroid (174 abstracts)

Treatment of disseminated non-radioiodine - avid papillary thyroid cancer with 90Y-DOTA-TATE preparation

N Szalus , G Kaminski , K Obuchowski , J Pietrzykowski , Z Podgajny , M Zagrodzka & E Dziuk


Military Institute of Health Services, Warsaw, Poland.


Introduction: Lack of radioiodine uptake in Differentiated Thyroid Carcinoma is a huge diagnostic and therapeutic problem. This sign is associated with worse prognosis. DOTA-TATE preparation is a somatostatin analogue coupled with 90 Y which emites β (−) radiation. Its use in a treatment depends on excessive expression of somatostatin receptors (SSTR) in malignant tumours.

The aim of the study: To present a possibility of treatment of non iodine – avid dissemnated papillary thyroid cancer with 90Y-DOTA-TATE preparation. The local Ethical Committee approval has been obtained before.

Material and methods: 73 y. o. male with dissemnated non-radioiodine - avid papillary thyroid cancer has been treated by 90Y-DOTA-TATE. Presence of SSTR was confirmed with use of 99mTc-HYNIC-TATE (Tektrotyd) preparation earlier. Both of these radiopreparations are produced by POLATOM – Swierk/Poland. In March, April and July 2005 this patient was treated with the 90Y-DOTA-TATE three times (3.7 GBq per dose). Nephroprotection was obtained by 10 hours infusion of 1000 ml 10% amino acids preparation with max. speed 120 ml/h.

Results: There wern’t observed any serious adverse events after 90Y-DOTA-TATE treatment. Non significant, transient decrease of thrombocytes and lymphocytes was observed. Thyreoglobuline serum concentration increase was considered as a sign of cancer destruction. The reduction of neoplasm infiltrations in site of thyroid removal and in mediastinum and lungs in CT scans was observed two months after the third 90Y-DOTA-TATE injection. Histopathological estimation of excised the new superficial meta tumours of the neck region showed mainly necrosis and calcifications.

Conclusions: 90Y-DOTA-TATE preparation seems to be useful and promising in treatment of non – radioiodine – avid papillary thyroid cancer.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.